Edwards Lifesciences (EW) Interest Coverage Ratio Growth (1y) (2010 - 2026)
Edwards Lifesciences (EW) Interest Coverage Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 129.62 Bn | 126.15 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 119.89 Bn | 110.67 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 74.01 Bn | 73.47 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 52.48 Bn | 48.23 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.64 Bn | 32.69 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.90 Bn | 31.79 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.41 Bn | 23.09 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 16.91% |
| 10 | Zimmer Biomet Holdings | 19.35 Bn | 18.94 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.66% |
| Mar 31, 2026 | 11.06% |
| Dec 31, 2025 | 61.33% |
| Sep 30, 2025 | -24.69% |
| Jun 30, 2025 | 2.69% |
| Mar 31, 2025 | 5.58% |
| Dec 31, 2024 | -160.09% |
| Sep 30, 2024 | -8.21% |
| Jun 30, 2024 | 27.43% |
| Mar 31, 2024 | -20.73% |
| Dec 31, 2023 | 4,921.32% |
| Sep 30, 2023 | -28.43% |
| Jun 30, 2023 | -56.26% |
| Mar 31, 2023 | -32.06% |
| Dec 31, 2022 | -66.56% |
| Sep 30, 2022 | -12.13% |
| Jun 30, 2022 | -28.22% |
| Mar 31, 2022 | -3.52% |
| Dec 31, 2021 | 143.35% |
| Sep 30, 2021 | -10.65% |